← Evidence map

TrialLeukemia2017

Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib.

W Qiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28819281